Experimental pharmacology study in mice-Narsoplimab (OMS721)
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Omeros Corporation
Start Date
July 6, 2021
End Date
July 5, 2022
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Omeros Corporation
Start Date
July 6, 2021
End Date
July 5, 2022